{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:46:46Z","timestamp":1791866806683,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08252-7","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:11:58Z","timestamp":1791864718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Building bone in the jaw with denosumab in adult Langerhans cell histiocytosis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3231-3357","authenticated-orcid":false,"given":"Polyzois","family":"Makras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kouveletsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Siska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kalkanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Yavropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Papapoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"8252_CR1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"8252_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","volume":"62","author":"AF de Groot","year":"2018","unstructured":"de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR (2018) The anti-tumor effect of RANKL inhibition in malignant solid tumors: a systematic review. Cancer Treat Rev 62:18\u201328","journal-title":"Cancer Treat Rev"},{"key":"8252_CR3","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2018-11-852459","volume":"133","author":"E Terpos","year":"2019","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Dimopoulos MA (2019) Myeloma bone disease: from biology findings to treatment approaches. Blood 133:1534\u20131539","journal-title":"Blood"},{"key":"8252_CR4","volume":"7","author":"S Tetradis","year":"2023","unstructured":"Tetradis S, Allen MR, Ruggiero SL (2023) Pathophysiology of Medication-Related Osteonecrosis of the Jaw-A Minireview. JBMR 7:e10785.","journal-title":"JBMR"},{"key":"8252_CR5","doi-asserted-by":"publisher","first-page":"E168","DOI":"10.1002\/ajh.26936","volume":"98","author":"P Makras","year":"2023","unstructured":"Makras P, Yavropoulou MP, Chatziioannou SN, Anastasilakis AD, Georgakopoulou D, Tsoli M, Chatzelis E, Kaltsas G (2023) Efficacy of denosumab monotherapy among adults with Langerhans cell histiocytosis: a prospective clinical trial. Am J Hematol 98:E168\u2013E171","journal-title":"Am J Hematol"},{"key":"8252_CR6","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal G, Tazi A, Go RS et al (2022) International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139:2601\u20132621","journal-title":"Blood"},{"key":"8252_CR7","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1210\/jc.2014-2654","volume":"100","author":"P Makras","year":"2015","unstructured":"Makras P, Salagianni M, Revelos K, Anastasilakis AD, Schini M, Tsoli M, Kaltsas G, Andreakos E (2015) Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis. J Clin Endocrinol Metab 100:E282\u2013E286","journal-title":"J Clin Endocrinol Metab"},{"key":"8252_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00198-025-07538-6","volume":"36","author":"P Makras","year":"2025","unstructured":"Makras P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, Papapoulos SE (2025) No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial. Osteoporos Int 36:1231\u20131237","journal-title":"Osteoporos Int"},{"key":"8252_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diab Endocrinol 5:513\u2013523","journal-title":"Lancet Diab Endocrinol"},{"key":"8252_CR10","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1210\/jc.2018-01965","volume":"104","author":"NB Watts","year":"2019","unstructured":"Watts NB, Grbic JT, Binkley N, Papapoulos S, Butler PW, Yin X, Tierney A, Wagman RB, McClung M (2019) Invasive oral procedures and events in postmenopausal women with osteoporosis treated with denosumab for up to 10 years. J Clin Endocrinol Metab 104:2443\u20132452","journal-title":"J Clin Endocrinol Metab"},{"key":"8252_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","volume":"107","author":"AD Anastasilakis","year":"2022","unstructured":"Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ (2022) Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS. J Clin Endocrinol Metab 107:1441\u20131460","journal-title":"J Clin Endocrinol Metab"},{"key":"8252_CR12","volume":"10","author":"D Masri","year":"2026","unstructured":"Masri D, Rosenfeld E, Adut S, Chaushu G, Tsvetov G, Avishai G, Ghanaiem O, Jonas E, Zlotogorski-Hurvitz A, Muchnik D (2026) The therapeutic window: timing dentoalveolar surgery to minimize MRONJ risk in denosumab-treated osteoporotic patients. JBMR 10:ziag038","journal-title":"JBMR"},{"key":"8252_CR13","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1210\/jc.2017-02669","volume":"103","author":"DW Dempster","year":"2018","unstructured":"Dempster DW, Brown JP, Fahrleitner-Pammer A, Kendler D, Rizzo S, Valter I, Wagman RB, Yin X, Yue SV, Boivin G (2018) Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 103:2498\u20132509","journal-title":"J Clin Endocrinol Metab"},{"key":"8252_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00774-020-01165-3","volume":"39","author":"M Tsukasaki","year":"2021","unstructured":"Tsukasaki M (2021) RANKL and osteoimmunology in periodontitis. J Bone Min Metab 39:82\u201390","journal-title":"J Bone Min Metab"},{"key":"8252_CR15","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/odi.13623","volume":"27","author":"EA Cafferata","year":"2021","unstructured":"Cafferata EA, Monasterio G, Castillo F, Carvajal P, Flores G, Diaz W, Fuentes AD, Vernal R (2021) Overexpression of MMPs, cytokines, and RANKL\/OPG in temporomandibular joint osteoarthritis and their association with joint pain, mouth opening, and bone degeneration: a preliminary report. Oral Dis 27:970\u2013980","journal-title":"Oral Dis"},{"key":"8252_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116184","volume":"153","author":"JI Aguirre","year":"2021","unstructured":"Aguirre JI, Castillo EJ, Kimmel DB (2021) Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone 153: 116184","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08252-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:11:59Z","timestamp":1791864719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08252-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":16,"alternative-id":["8252"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08252-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"2 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Institutional review board approval was obtained according to the policy of the 251 Hellenic Air Force & VA General Hospital.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PM has received research grants from Amgen and Galenica and lecture and\/or advisory board fees from Amgen, UCB, Galenica, Bianex, and Elpen. MPY has received lecture and\/or advisory board fees from UCB and Galenica. ADA has received lecture fees from Amgen, Bianex, Eli Lilly, Galenica, and UCB. SP has received consulting and\/or speaker fees from Amgen, Qualix Dot, and UCB. MK, IS, and DK declare that they have no conflicts of interest relevant to this work.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for participation and publication of this case report and accompanying images.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}